MedTrace Logo

Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)

NCT00739219 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2009-01-21

No results posted yet for this study

Summary

This study is designed to show that pharmacotherapy guided by eNO and clinical standard of care produces a superior outcome to trial-based therapy guided by clinical standard of care alone.

Conditions

Interventions

DEVICE

Apieron Insight eNO monitor

The Apieron Insight(tm) eNO monitor is used to measure exhaled nitric oxide, and asthma is managed to keep eNO below an individualized target.

Sponsors & Collaborators

  • Apieron

    lead INDUSTRY

Principal Investigators

  • William E Berger, MD, MBA · Southern California Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00739219 on ClinicalTrials.gov